LAMA2–ASSOCIATED CONGENITAL MUSCULAR DYSTROPHY: CASE REPORT

Introduction: LAMA2 Associated Muscular Dystrophy (LAMA2-RD) is one of the most common forms of congenital muscular dystrophy worldwide. Mutations in the LAMA2 gene affect the production of the α2 subunit of lamin-211 (merosine) and result in partial or complete deficiency of lamin-211. Inheritance is usually autosomal recessive. Case report: We present a patient who is dual heterozygous for two pathogenic variants in the LAMA2 gene, as demonstrated by targeted resection of 4800 clinically significant genes. c.4474dupT, p. (Tyr1492LeufsTer11), inherited from the mother and c.7732C> T, p. (Arg2578Ter), inherited from the father. With this genotype the patient is confirmed autosomal recessive disease, LAMA2-RD. Variant c.4474dupT, p. (Tyr1492LeufsTer11), in exon 31 of the LAMA2 gene, is a change that has not been reported in the literature. Conclusion: Genetic confirmation of the diagnosis is important for genetic counseling, prenatal diagnosis for each subsequent pregnancy in the family because the risk of an affected child is 25%.

[1]  F. Muntoni,et al.  LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness , 2020, Frontiers in Molecular Neuroscience.

[2]  D. Cuadras,et al.  Epilepsy in LAMA2‐related muscular dystrophy: An electro‐clinico‐radiological characterization , 2020, Epilepsia.

[3]  M. Mora,et al.  Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI , 2019, Neuromuscular Disorders.

[4]  J. D. den Dunnen,et al.  LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin‐α2 variome and its related phenotypes , 2018, Human mutation.

[5]  I. Dimova,et al.  LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient , 2018, Case reports in genetics.

[6]  D. Love,et al.  Merosin-deficient congenital muscular dystrophy: A novel homozygous mutation in the laminin-2 gene , 2015, Journal of Clinical Neuroscience.

[7]  Y. Jiang,et al.  Genotype/phenotype analysis in Chinese laminin‐α2 deficient congenital muscular dystrophy patients , 2015, Clinical genetics.

[8]  Xiwei Shan,et al.  The Extracellular Matrix Protein Laminin α2 Regulates the Maturation and Function of the Blood–Brain Barrier , 2014, The Journal of Neuroscience.

[9]  S. Duarte,et al.  Atypical phenotype in two patients with LAMA2 mutations , 2014, Neuromuscular Disorders.

[10]  R. Webster,et al.  A case series of general anesthesia in children with laminin alpha2 (merosin)‐deficient congenital muscular dystrophy , 2014, Paediatric anaesthesia.

[11]  E. Bertini,et al.  Congenital Muscular Dystrophies: A Brief Review , 2011, Seminars in pediatric neurology.

[12]  V. Sukhorukov,et al.  [Merosin-deficient congenital muscular dystrophy]. , 2010, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[13]  M. Mora,et al.  LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[14]  U. Ramadhyani,et al.  Suspected malignant hyperthermia in a child with laminin α2 (merosin) deficiency in the absence of a triggering agent , 2006, Paediatric anaesthesia.

[15]  P. Guicheney,et al.  Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin) , 2002, European Journal of Human Genetics.

[16]  G. Bydder,et al.  Cognitive abilities in children with congenital muscular dystrophy: correlation with brain MRI and merosin status , 1999, Neuromuscular Disorders.

[17]  T. Crawford,et al.  Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. , 1998, Neurology.